Skip to main content
Premium Trial:

Request an Annual Quote

USPTO Publishes One RNAi-Related Patent Application: Jan 17, 2008

Premium
Title: Methods, Libraries, and Computer Program Products for Determining Whether siRNA-Induced Phenotypes are Due to Off-Target Effects
 
Number: 20080009012
 
Filed: July 6, 2007
 
Lead Inventor: Amanda Birmingham, Dharmacon (Thermo Fisher Scientific)
 
The patent application, its abstract states, claims “methods, libraries, and computer program products for determining whether a phenotype induced by a candidate siRNA for a target gene in an RNAi experiment is target specific or a false positive. Through the use of a control siRNA that has one or two seed sequences of six or seven bases in combination with a neutral scaffolding sequence, a distinction can be made between false positive and true positive analyses of functionality.”

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.